EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Selective neuronal vulnerability in Alzheimer’s disease: Mechanisms, biomarkers, and therapeutic implications

Xu Tian-Yang, E Er-Deng, Zhang Ting, Zhang Xiao-Qin

Ageing Research Reviews · 2027-01 · 123 · 103430

DOI: 10.1016/j.arr.2026.103430 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2027-01. Verfasst von Xu Tian-Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, China. Die Arbeit nennt 157 Literaturangaben. Gefördert von: Zhejiang Province Natural Science Foundation, Ningbo Municipal Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is characterized by marked heterogeneity in the timing and extent of neuronal dysfunction and degeneration. Specific neuronal populations, including entorhinal cortex layer II stellate cells, hippocampal CA1 pyramidal neurons, basal forebrain cholinergic neurons, locus coeruleus noradrenergic neurons, and prefrontal parvalbumin interneurons, show different combinations of functional, pathological, and degenerative vulnerability during disease progression. The strength and nature of this evidence, however, vary across neuronal populations and between human studies and experimental models. Selective vulnerability is therefore unlikely to reflect a single cell-type-specific mechanism. Instead, pathological stress in AD interacts with intrinsic cellular properties, circuit organization, and the local microenvironment. Metabolic stress, axonal transport impairment, excitotoxicity and Ca²⁺ dysregulation, neuroinflammation, lipid dysregulation and ferroptotic stress, and proteostasis failure may consequently produce distinct functional and degenerative outcomes across neuronal populations. Advances in transcriptomics, neuropathology, multimodal imaging, and circuit-level analyses are also identifying molecular, regional, and functional measures associated with early involvement of vulnerable neuronal systems, although validated cell-type-specific biomarkers remain limited. In this Review, we integrate these findings to examine the evidence for selective neuronal vulnerability, the mechanisms that may modify neuronal susceptibility, and their implications for biomarker development and therapy. We further consider how vulnerability-informed strategies could complement pathology-directed therapies by aligning therapeutic mechanisms with prominent cellular or circuit dysfunction and disease stage. This perspective may help explain the spatial and temporal heterogeneity of AD and guide more biologically informed approaches to early detection and intervention.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseBiomarkersCircuit dysfunctionSelective neuronal vulnerabilityTherapeutic strategies

Autor:innen und Institutionen

  • Department of Pharmacology, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, China.
  • Department of Pharmacology, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, China. Electronic address: zhangxiaoqin1@nbu.edu.cn.

Förderung

  • Zhejiang Province Natural Science Foundation
  • Ningbo Municipal Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Tian-Yang, X., Er-Deng, E., Ting, Z., & Xiao-Qin, Z. (2027). Selective neuronal vulnerability in Alzheimer’s disease: Mechanisms, biomarkers, and therapeutic implications. Ageing Research Reviews, 123, 103430. https://doi.org/10.1016/j.arr.2026.103430

Vancouver

Tian-Yang X, Er-Deng E, Ting Z, Xiao-Qin Z. Selective neuronal vulnerability in Alzheimer’s disease: Mechanisms, biomarkers, and therapeutic implications. Ageing Research Reviews. 2027;123:103430. doi:10.1016/j.arr.2026.103430

BibTeX
@article{TianYang2027,
  author = {Tian-Yang, Xu and Er-Deng, E and Ting, Zhang and Xiao-Qin, Zhang},
  title = {Selective neuronal vulnerability in Alzheimer’s disease: Mechanisms, biomarkers, and therapeutic implications},
  journal = {Ageing Research Reviews},
  year = {2027},
  volume = {123},
  pages = {103430},
  doi = {10.1016/j.arr.2026.103430}
}
Kostenlos starten →